DeutschNewstral
Article
newatlas.com on 2021-06-08 03:09
First new Alzheimer’s drug in decades receives controversial FDA approval
Related news
“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugsTechCrunch
FDA approves Biogen’s controversial Alzheimer’s drugNew York Post
FDA conditionally approves controversial Alzheimer’s drugThe Hindu
Eli Lilly to seek FDA approval for Alzheimer’s drug that firm says slows cognitive declineAlaska Dispatch News- FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”newatlas.com
- FDA calls for federal investigation into approval of Alzheimer’s drugNew York Post
First CBD Drug Receives FDA Approvaljdsupra.com
FDA panel reviews 1st new Alzheimer’s drug in 2 decadesstaradvertiser.com- FDA approved controversial Alzheimer’s drug despite objections from staffNew York Post
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approvalobserver.com
FDA committee votes against approval of controversial muscular dystrophy drugWashington Post
Controversial FDA Approval Of Alzheimer’s Drug Aducanumab Sets Stage For Possible Medicare Coverage BattleForbes- Manchin Wants Biden To Oust FDA Chief Over Controversial Alzheimer’s Drug ApprovalForbes
- FDA Approves Controversial Alzheimer’s Drug, the First of Its Kind in 20 Yearsobserver.com
Emergent receives FDA approvalthedailyrecord.com
GTx receives FDA approvalbizjournals.com
Three experts resign as FDA advisors over approval of Alzheimer’s drugArs Technica- Tesaro Receives Early FDA Approval for Ovarian Cancer Drug Zejulajdsupra.com
- Apple's Latest Watch Receives FDA Approval For ECG Functionalityjdsupra.com